These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Reversal of Roux-en-Y Gastric Bypass for Successful Salvage of Renal Allograft. Hrebinko K, Moroni E, Ganoza A, Puttarajappa CM, Molinari M, Sood P, El Hag M, Wijkstrom M, Tevar AD. Am Surg; 2023 Apr; 89(4):1286-1289. PubMed ID: 33631945 [Abstract] [Full Text] [Related]
4. Amelioration of anemia after kidney transplantation in severe secondary oxalosis. Bernhardt WM, Schefold JC, Weichert W, Rudolph B, Frei U, Groneberg DA, Schindler R. Clin Nephrol; 2006 Mar; 65(3):216-21. PubMed ID: 16550754 [Abstract] [Full Text] [Related]
5. Plasma oxalate in relation to eGFR in patients with primary hyperoxaluria, enteric hyperoxaluria and urinary stone disease. Perinpam M, Enders FT, Mara KC, Vaughan LE, Mehta RA, Voskoboev N, Milliner DS, Lieske JC. Clin Biochem; 2017 Dec; 50(18):1014-1019. PubMed ID: 28764885 [Abstract] [Full Text] [Related]
6. Risk of nephrolithiasis, hyperoxaluria, and calcium oxalate supersaturation increased after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis. Upala S, Jaruvongvanich V, Sanguankeo A. Surg Obes Relat Dis; 2016 Dec; 12(8):1513-1521. PubMed ID: 27396545 [Abstract] [Full Text] [Related]
8. Secondary oxalate nephropathy and kidney transplantation. Aziz F, Jorgenson M, Garg N. Curr Opin Organ Transplant; 2023 Feb 01; 28(1):15-21. PubMed ID: 36342385 [Abstract] [Full Text] [Related]
9. Potential for bilateral nephrectomy to reduce oxalate release after combined liver and kidney transplantation for primary hyperoxaluria type 1. Mizusawa Y, Parnham AP, Falk MC, Burke JR, Nicol D, Yamanaka J, Lynch SV, Strong RW. Clin Transplant; 1997 Oct 01; 11(5 Pt 1):361-5. PubMed ID: 9361924 [Abstract] [Full Text] [Related]
10. Medical Management of Advanced Oxalate Nephropathy Secondary to Gastric Bypass Surgery. Kamel TH, Maroz N. Am J Med Sci; 2021 Apr 01; 361(4):517-521. PubMed ID: 33187632 [Abstract] [Full Text] [Related]
11. Hyperoxaluria in a Model of Mini-Gastric Bypass Surgery in Rats. Ormanji MS, Korkes F, Meca R, Ishiy CSRA, Finotti GHC, Ferraz RRN, Heilberg IP. Obes Surg; 2017 Dec 01; 27(12):3202-3208. PubMed ID: 28550437 [Abstract] [Full Text] [Related]
14. The Long Pentraxin PTX3 Is an Endogenous Inhibitor of Hyperoxaluria-Related Nephrocalcinosis and Chronic Kidney Disease. Marschner JA, Mulay SR, Steiger S, Anguiano L, Zhao Z, Boor P, Rahimi K, Inforzato A, Garlanda C, Mantovani A, Anders HJ. Front Immunol; 2018 Dec 01; 9():2173. PubMed ID: 30319631 [Abstract] [Full Text] [Related]
15. Acute irreversible oxalate nephropathy in a lung transplant recipient treated successfully with a renal transplant. Dheda S, Swaminathan R, Musk M, Sinniah R, Lawrence S, Irish A. Nephrology (Carlton); 2012 Apr 01; 17 Suppl 1():12-5. PubMed ID: 22497648 [Abstract] [Full Text] [Related]
17. Clinicopathologic Characteristics, Etiologies, and Outcome of Secondary Oxalate Nephropathy. Nasr SH, Valeri AM, Said SM, Sethi S, Nath KA, Lieske JC, Bu L. Mayo Clin Proc; 2024 Apr 01; 99(4):593-606. PubMed ID: 38310502 [Abstract] [Full Text] [Related]
18. Bilateral native nephrectomy reduces systemic oxalate level after combined liver-kidney transplant: A case report. Villani V, Gupta N, Elias N, Vagefi PA, Markmann JF, Paul E, Traum AZ, Yeh H. Pediatr Transplant; 2017 May 01; 21(3):. PubMed ID: 28261895 [Abstract] [Full Text] [Related]
19. Combined liver-kidney transplantation in primary hyperoxaluria type 1. Bone histopathology and oxalate body content. Toussaint C, Vienne A, De Pauw L, Gelin M, Janssen F, Hall M, Schurmans T, Pasteels JL. Transplantation; 1995 Jun 27; 59(12):1700-4. PubMed ID: 7604440 [Abstract] [Full Text] [Related]
20. Oxalate nephropathy in a diabetic patient after gastric by-pass. Moutzouris DA, Skaneli G, Margellos V, Apostolou T, Petraki C, Nikolopoulou N. Clin Nephrol; 2011 Feb 27; 75 Suppl 1():16-9. PubMed ID: 21269587 [Abstract] [Full Text] [Related] Page: [Next] [New Search]